Começar
Long

ATNF | Is My Math Off? | LONG

547
1180 Life Sciences Corp., a clinical-stage biotechnology company, develops therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. Its product development platforms include fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which is under Phase IIb clinical trials that focuses on fibrosis and Anti-TNF; Synthetic Cannabidiol (CBD) Analogs platform, which is under preclinical trials that are man-made derivatives of CBD; and a7nAChR platform, an immune suppressive, which is under preclinical trails that focuses on alpha 7 nicotinic acetylcholine receptor. The company was incorporated in 2016 and is headquartered in Palo Alto, California.
DivergenceSeeker
99% of the market trades the noise. I trade the math. Professional divergence hunter and volume tracker. Enter the Seeker Lab:

linktr.ee/DivergenceSeeker
Também em:
biotechnologyBullish DivergencehealthcareTechnical Indicatorsoversold

Aviso legal

As informações e publicações não se destinam a ser, e não constituem, conselhos ou recomendações financeiras, de investimento, comerciais ou de outro tipo fornecidos ou endossados pela TradingView. Leia mais nos Termos de Uso.
biotechnologyBullish DivergencehealthcareTechnical Indicatorsoversold
DivergenceSeeker
99% of the market trades the noise. I trade the math. Professional divergence hunter and volume tracker. Enter the Seeker Lab:

linktr.ee/DivergenceSeeker
Também em:

Aviso legal

As informações e publicações não se destinam a ser, e não constituem, conselhos ou recomendações financeiras, de investimento, comerciais ou de outro tipo fornecidos ou endossados pela TradingView. Leia mais nos Termos de Uso.